The seven-year legal crusade waged by South African Olympic champion Caster Semenya against global sex eligibility rules in track and field has quietly reached its conclusion. In October 2025, her legal team confirmed that they would not pursue further appeals to the Swiss Supreme Court, despite securing a landmark victory at the European Court of Human Rights (ECtHR) months earlier. This decision marks the end of one of sport’s most divisive and protracted sagas, one that transformed the two-time 800-meter gold medalist into the face of a complex global debate spanning human rights, biology, and fairness in women’s sports. While the ECtHR ruled that Semenya had not received a fair hearing, the decision did not overturn the World Athletics regulations themselves, leaving the champion unable to compete in her signature event without taking hormone-suppressing medication. Having shifted her focus to coaching and advocacy, Semenya’s exit from the courtroom signifies the closure of a deeply personal fight that ultimately came too late to save her career.
The High Price of an Unfair Hearing
Caster Semenya’s legal journey began in 2018 when she formally challenged the World Athletics (formerly IAAF) regulations that required female athletes with differences in sex development (DSD) and high natural testosterone levels to medically reduce those levels to compete in specific events, including the 400m, 800m, and 1500m.
After initial losses at the Court of Arbitration for Sport (CAS) and the Swiss Federal Tribunal, Semenya pursued her case to the European Court of Human Rights. In July 2025, she achieved a significant, albeit partial, victory. The ECtHR ruled that the Swiss Federal Tribunal had failed to carry out the “rigorous judicial review” required to protect her rights, finding that she had been denied a fair hearing process. This ruling was lauded by human rights organizations as a victory for athletes’ rights globally, demonstrating that sporting bodies and their judicial review processes must be held accountable to international human rights norms regarding discrimination and privacy.
Despite the highly successful outcome on the procedural front, the ruling did not overturn the World Athletics regulations themselves. The court dismissed other elements of her appeal concerning discrimination, maintaining that the core argument—whether the rules were necessary or proportionate—was not fully within its jurisdiction. This meant that even with the legal triumph, Semenya remained ineligible to compete without adhering to the rules she found discriminatory and detrimental to her health.
The Evolution of the Eligibility Battleground
Semenya’s seven-year legal marathon was fought against a backdrop of continuously tightening regulations by World Athletics, underscoring the organization’s commitment to maintaining a female category defined by specific biological criteria.
World Athletics has consistently argued that DSD athletes like Semenya, who possess a typical male XY chromosome pattern and testosterone levels in the male range, gain a significant, unfair athletic advantage over other women due to testosterone’s effect on muscle mass and cardiovascular performance. In response to the complexities of the legal and scientific debate, the governing body introduced a new framework that took effect in September 2025. This updated rule moved beyond the disputed threshold of testosterone monitoring and now requires women competing in international track to undergo a genetic test to check for the presence of a Y chromosome. This regulatory shift effectively raised the bar for eligibility, ensuring that even Semenya’s legal victory on fair process would not clear her path back to the track.
A Legacy Beyond the Track and Field
The decision to conclude the legal battle was framed by Semenya’s legal team as a recognition that their client had reached “the highest possible court with a highly successful outcome,” and that the challenge would not be taken further under the circumstances.
However, the quiet conclusion belies the profound personal toll the fight exacted. Semenya, a two-time World Champion and two-time Olympic gold medalist, has been barred from running her preferred 800-meter event at major international meets since 2019 because she refused to take the prescribed hormone-suppressing medication, which she stated made her feel physically unwell. Her enforced retirement from elite competition led her to shift her focus toward coaching and advocacy, sharing her story in her memoir, The Race to Be Myself. While the ban curtailed her athletic career, her struggle has permanently influenced global sports policy, forcing a crucial dialogue about biological diversity, human rights, and the ethical boundaries of competitive fairness.
